The ECHELON-2 Trial: 5-year results of a randomized, phase III study of brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma
| Image |  |
|---|---|
| Description | |
| Author/s |
author: Tim M. Illidge Swaminathan Padmanabhan Ranjana H. Advani Andreas Hüttmann |
| Publication date | March 2022 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |